Moberg Pharma AB (publ) announced the nomination committee consist of the Chairman Gillis Cullin representing Östersjöstiftelsen, Anders Lundmark, Martin Öhrn and Peter Wolpert, Chairman of the Board of Directors in the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.04 SEK | +0.65% | -27.40% | +84.47% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+84.47% | 71.83M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- MOB Stock
- News Moberg Pharma AB
- Moberg Pharma AB Announces Composition of Nomination Committee